Single Tooth Restoration in the Maxillary Esthetic Zone Using a One-Piece Ceramic Implant with 1 Year of Follow-Up: Case Series by Vilor Fernández, Miren et al.
RESEARCH Open Access
Single tooth restoration in the maxillary
esthetic zone using a one-piece ceramic
implant with 1 year of follow-up: case
series
Miren Vilor-Fernández1, Ana-María García-De-La-Fuente1* , Xabier Marichalar-Mendia2, Ruth Estefanía-Fresco1 and
Luis-Antonio Aguirre-Zorzano1
Abstract
Background: Oral implants have helped clinicians to improve the quality of life for many patients. The material of
choice for dental implants currently remains titanium type IV, whose mechanical and biological properties have
been proven throughout the history of implantology. Yet, this material is not exempt from complications. For these
reasons, ceramic alternatives to titanium have emerged. Thus, the purpose of this study is to evaluate peri-implant
hard and soft tissue stability with the use of a one-piece ceramic implant (Straumann® PURE Ceramic Implant)
during 1 year of follow-up.
Study design: One-piece all-ceramic zirconia (ZrO2) implants were placed to replace single missing teeth in the
esthetic zone. Six to 8 weeks after the procedure, the definitive prosthesis was fabricated. At the time of prosthesis,
placement (T0) photographs and periapical radiographs were taken, and the following clinical parameters were
recorded: probing depth (PD), plaque index (PI), bleeding on probing (BOP), suppuration on probing (SOP), distance
from gingival margin to incisal edge (GM-IE), and Jemt papilla index (JPI). Follow-up appointments were scheduled
at 4 (T4), 8 (T8), and 12 (T12) months, when the same parameters were recorded. In addition, plaque control was
reinforced and prophylaxis was carried out. In this last appointment, a final periapical radiograph was taken to
assess marginal bone loss.
Results: A total of 32 zirconia implants were placed in 28 patients (16 women and 12 men, aged between 34 and
67 years). The survival and success rate were 96.9%. The increase in probing depth from baseline to 12 months was
0.78 mm. Assessments of plaque index and bleeding on probing showed a slight increase throughout the study.
Conclusions: The results obtained with the Straumann® PURE Ceramic implants show them to exhibit very good
clinical behavior. The survival rate of the implants of our pilot study was 96.9%. For these reasons, we can say that
zirconia implants could be an alternative to titanium implants in the esthetic zone.
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Background
Oral implants have helped clinicians to improve the
quality of life for many patients. The material of choice
for dental implants currently remains titanium type IV,
whose mechanical and biological properties have been
proven throughout the history of implantology [1, 2].
Yet, this material is not exempt from complications.
First, this type of metallic implant can have esthetic limi-
tations, especially when used in anterior regions and in
patients with a thin biotype. The complications to which
we refer are the appearance of a metallic margin due to
recession, or grayish colorations due to the translucency
of the metal through the peri-implant mucosa [3–5].
Second, some studies have reported immunological reac-
tions to titanium particles which lead to biological com-
plications [6, 7], while others have demonstrated allergic
reactions to titanium, including Sicilia et al. (2008) who
observed a prevalence of 0.6% [8, 9]. Finally, it must also
be taken into account that the number of patients who
demand “metal-free” implants is increasing.
For these reasons, ceramic alternatives to titanium
have emerged. The first ceramic implants arrived on the
market more than 40 years ago. They were made of alu-
mina, a material prone to fracture when loaded unfavor-
ably [10], and so, they are no longer available. Currently,
the material of choice for the manufacture of ceramic
implants is yttria tetragonal zirconia polycrystal (Y-
TZP), characterized by its high resistance to fracture, a
low modulus of elasticity, a low affinity to plaque and
high biocompatibility [11–14].
The objective of this pilot study was to evaluate the
stability of hard and soft peri-implant tissues with the
use of a one-piece ceramic implant (Straumann® PURE
Ceramic Implant Monotype) with a 1-year follow-up.
Materials and methods
Study design
This project began, initially, as a pilot study, which con-
sists of a retrospective part and a prospective follow-up
part. This observational ambispective clinical study was
approved by the Clinical Research Ethics Committee of
the Basque Country (CEIC-E) (Internal Code PI2016088,
07/2016). In addition, it is registered at www.Clinical-
Trials.com (n° NCT03352284).
Study population
Patients who met the following inclusion criteria were
included in the study:
1. Patients treated in Own Master of Periodontology
and Osseointegration in the University of the
Basque Country (UPV/EHU)
2. Age > 18 years
3. One single tooth missing in the anterior maxilla
(1.5–2.5)
4. Plaque index <20% [15]
5. Bleeding on probing index <20% [16]
6. Periodontally healthy or treated periodontal
conditions
7. Is able to fully understand the nature of the
proposed surgery and is able to provide signed
informed consent
Conversely, patients who presented any of the follow-
ing exclusion criteria were not included in the study:
1. General contraindications to dental and/or surgical
treatment
2. Is taking medications or receiving treatments which
have an effect on healing in general (e.g., steroids or
large doses of anti-inflammatory drugs)
3. Untreated periodontal conditions
4. Not willing to participate
In this way, a total of 28 patients (16 women and 12
men) with a mean age of 54.1 years [34-67 years] who
required dental implants to replace a single tooth in the
maxilla were recruited to participate in the study, and all
of them were properly informed and signed a written in-
formed consent.
Clinical and radiographic evaluation
All-ceramic one-piece implants (PURE Ceramic Im-
plants Monotype, Institut Straumann AG, Basel,
Switzerland) were used.
Before surgery, a clinical and radiographic diagnostic
assessment was carried out to choose the appropriate
implant for each case. To locate the 3D implant position,
the following minimal distances were taken into consid-
eration: minimum 1.5 to 2 mm from the natural adja-
cent teeth, 1 mm palatal to the ideal point of emergence,
and 2 mm apical to the midfacial gingival margin of the
final implant prosthesis [17]. A minimum of 1.5 mm to
2 mm thickness of buccal bone was preserved as well.
The implant diameter and the length were chosen ac-
cording to each individual case. These implants had two
different abutment heights: 4 and 5.5 mm, and for the
selection of the implant, all these considerations (pos-
ition of natural teeth, width of alveolar ridge and occlu-
sion) were taken into consideration in the planification
of the treatment of each patient. Finally, study models
were made to manufacture splints for use as surgical
guides for each patient.
All surgeries were performed under local anesthesia
with articaine (Meganest ® 1:200.000, Clarben, Madrid,
Spain). The surgical technique consisted in the elevation
of a full-thickness mucoperiosteal flap, both vestibular
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and palatal, through a mid-crestal incision. After the al-
veolar bone had been exposed, the drilling sequence was
carried out according to the manufacturer’s instructions
before the placement of the fixture. In some cases where
bone volume was insufficient, dehiscence or fenestra-
tions were treated by the guided bone regeneration tech-
nique with xenograft (Bio-Oss®, Geistlich Pharma AG,
Wolhusen, Switzerland) and resorbable collagen mem-
brane (Collagene AT®, Centro de Odontoiatria Operativa
S.R.L, Podova, Italy). Once the implant had been
inserted, a healing cap was placed in almost all cases and
the flap was closed and sutured (Fig. 1a–d).
In 18 of the cases (56.3%), an immediate provisional
crown was made due to the esthetic demands of the pa-
tients. In this case, primary stability with an insertion
torque > 30 Ncm was confirmed and a pre-formed
polycarbonate crown of the appropriate size was
chosen. That crown was overlaid with a self-curing
resin (Tab 2000, Kerr, Scafati, Italy) and composite
(TPH Spectrum®, Dentsply Sirona, York, Pensilvania,
USA) and then polished perfectly. The crown was
cemented with Temp-Bond (Temp-Bond™, Kerr, Scafati,
Italy), and the occlusion was verified to check that there
was no contact during centric or eccentric movements to
prevent loading during osseointegration.
Post-operative instructions included amoxicillin 750
mg every 8 h for 8 days, dexketoprofen 25 mg every 8 h
for 4 days, and rinsing with chlorhexidine digluconate
0.12% twice a day for 15 days. Sutures were removed
after 7 days.
After 6 to 8 weeks of healing and following the manu-
facturer’s recommendations, final impressions were
taken using the corresponding impression cap with a
closed tray and VPS impression material of putty (Emp-
ress™ 2 Putty Soft, 3M ESPE, Seefeld, Germany) and
ultra-light viscosity (Empress™ 2 Ultra-Light Body Quick,
3M ESPE, Seefeld, Germany). Due to the one-piece de-
sign of the ceramic implant, all-ceramic zirconia crowns
were inserted in all cases. Permanent glass ionomer ce-
ment (Ketac Cem™, 3M ESPE, Seefeld, Germany) was
used to cement the crowns directly onto the implant
abutment. Special attention was paid to remove all
remaining cement.
After placement of the definitive prosthesis (T0), we
carried out photography, intra-oral radiography, and
measurements of probing depth, bleeding on probing,
maximum distance from the gingival margin to the inci-
sal edge, and Jemt papilla index, and took these parame-
ters as the baseline from which any changes were
evaluated.
In each of the follow-up appointments, 4 (T4), 8 (T8)
and 12 months (T12) after the placement of the prosthesis,
plaque control was reinforced, whatever supragingival
plaque that could be removed was removed, a photograph
of the restoration was taken, and the following parameters
were recorded by one of the researchers (MV):
Fig. 1 Clinical case. a Surgery, b implant placed, c radiographic evaluation at 12 months, and d prosthesis at 12 months
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 Probing depth (PD): pocket probing on dental
implants was recorded with light force
(approximately 0.25N) at six points around the
implant.
 Bleeding on probing (BOP) (at six points around the
implant) [16]
 Suppuration on probing (SOP): local SOP score was
recorded as the percentage of total surfaces (six
points per implant) that exhibited suppurating on
gentle probing with a light force (approximately
0.25N)
 Plaque index [15]
 Peri-implant recession (Pi-Rec): the difference
between maximum distance from the gingival
margin to the incisal edge measured at baseline and
1 year-follow-up, measured on the mid buccal site.
 Jemt papilla index (JPI) [18]
At the last follow-up appointment, an X-ray was also
performed to assess bone changes, namely any loss or
gain as measured at the mesial and distal aspect of each
implant relative to the baseline measurements at the be-
ginning of the study. The final photograph was used to
analyze soft tissue changes, namely peri-implant reces-
sion (Pi-Rec) and the state of the papilla according to
the Jemt papilla index [18].
All radiographic measurements were taken by the
same investigator (RE), at baseline (T0) and at 12
months (T12). Changes in the bone level were measured
both mesially and distally of the implant on a periapical
X-ray taken with a standardized film holder (Rinn® Flip-
Ray Film Holder, Rinn, Dentsply International Inc. Elgin,
IL, EEUU). The length of the polished neck of the im-
plant (1.8 mm) served as a reference to calibrate the X-
ray before measuring marginal bone loss (MBL) from
the neck of the implant to the first bone-implant contact
(BIC). A positive value indicated that the first BIC was
located above the first thread of the implant, and a nega-
tive one indicated that it was located below.
Statistical analysis
The data were analyzed by XM using IBM SPSS software
version 22. For descriptive statistics, we used the mean,
standard deviation, rank, and percentages. For analytical
statistics, the Wilcoxon signed-rank test for related sam-
ples was carried out. P values of less than 0.05 were con-
sidered statistically significant.
Results
Thirty-two Straumann® PURE Ceramic implants were
placed by only one surgeon (MV) in 28 patients. The di-
ameters of the implants were 3.3 and 4.1 mm, and the
lengths ranged from 8 to 14 mm. These implants had
two different abutment heights: 4 and 5.5 mm. Twenty-
three implants were placed in the premolar region
(71.9%), four in the canine position (12.5%), and five in
the lateral incisor position (15.6%). The patient demo-
graphics and implant characteristics are described in
Table 1.
In nine of the surgeries (28.12%), an additional bone
regenerative procedure was required due to dehiscences
that arose from implant placement. Additionally, in four
cases (12.5%), a connective tissue graft was placed to in-
crease the soft tissue volume. It should be noted that no
patient had postoperative complications, instead of two
cases (6.25%) that, during the healing phase, showed mo-
bility and the implant had to be removed. Thus, the sur-
vival rate obtained in this study was 96.9%.
Soft tissues
Probing depth increased slightly over the study time. Ini-
tially, at the time of the final crown placement (T0), the
mean PD was 2.81 ± 1.03 mm and it progressively in-
creased in T4, T8, and T12 with the mean PD of 3.31 ±
0.95 mm, 3.37 ± 0.94 mm, and 3.59 ± 1.37 mm, respect-
ively. We observed a statistically significant difference in
Table 1 Summary of patient demographics and implant
characteristics (n = 32 implants)
N (%)
Patient data
Sex, n 16 females
12 males
Gender: n and (%) female 16 (57.15)
Mean age (years) 54.1
Age range (years) 34–67
Smokers 8 (31.3)
Implant data
Site of implant placement (n and %)
Lateral incisor 5 (15.6)
Canine 4 (12.5)
1st Premolar 19 (59.4)
2nd Premolar 4 (12.5)
Length of implant, n (%)
8 mm 2 (6.25)
10 mm 20 (62.5)
12 mm 8 (25)
14 mm 2 (6.25)
Immediate implant 4 (12.5)
Bone augmentation, n (%) 9 (28.12)
Soft tissue augmentation, n (%) 4 (12.5)
Provisional restoration 18 (56.3)
Follow-up (months) 12
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PD between baseline and 12 months of 0.78 mm (p =
0.002) (Fig. 2).
In relation to the PI [15] at the beginning, at 4, 8, and
12 months after the placement of the prosthesis, this re-
vealed a percentage of surfaces with dental plaque of
19.55 ± 7.22%, 20.53 ± 8.67%, 21.77 ± 6.35%, and 20.67
± 7.53%, respectively (Fig. 3).
Bleeding on probing (BOP) remained stable through-
out the study; thus, in T0, T4, T8, and T12 were 23.26 ±
27.18%, 18.53 ± 16.11%, 29.5 ± 22.43%, and 26.3 ±
26.41%, respectively (Fig. 4). There were no significant
differences between any of the study times.
It should be noted that of the 30 implants studied, after
1 year, 28 of them did not have any Pi-Rec. Only two im-
plants experienced a Pi-Rec of 1 mm, assuming an average
Pi-Rec of 0.07 mm after 1 year of follow-up. None of both
implants showing recession were either an immediate
implant or treated with regenerative procedures.
On the other hand, the Jemt papillae index (JPI)
showed an improvement regarding the filling of the in-
terproximal spaces, probably, due to the maturation of
the papillae. Thus, initially 37.5% of the cases showed an
JPI = 0, 37.5% JPI = 1, 12.5% JPI = 2, and 9.5% JPI = 3.
After 12 months, the percentages were 9.4%, 40.6%,
31.3%, and 12.5%, respectively. The mean JPI of T0 was
0.94, while in T12, it was 1.5, indicating that in several
of the cases the papilla was in a more coronal position at
the end of the study.
Hard tissues
Marginal bone loss (MBL) from implant placement to
prosthetic loading on the mesial aspect was 0.46 ± 0.53
mm (p <0.001) and on the distal aspect 0.41 ± 0.54 mm
(p < 0.001). Twelve months after the prosthetic loading,
the mean MBL compared to surgery was 0.73 ± 0.62
mm mesially and 0.83 ± 1.09 mm distally, both statisti-
cally significant (p < 0.001) (Fig. 5).
Discussion
Our pilot study evaluated the stability of hard and soft
tissues around Straumann® PURE Ceramic implants, and
this stability is considered a determining factor for a suc-
cessful result. According to the conclusions established
during the first European Workshop on Periodontology,
MBL <1.5 mm after the first year of loading and an add-
itional 0.2 mm annually should be taken as a successful
treatment [19]. To compare the results available in the
literature, we selected the studies that include single
crowns cemented over one-piece ceramic implants. The
success rate is a variable which few studies have men-
tioned, but the survival rate is reported by numerous ar-
ticles. A systematic review that included nine articles
with 326 patients and 398 implants, and a follow-up
time which ranged from 12 months to 5 years reported a
survival rate of 95.6% [20], the same as the 95% reported
by Payer et al. [21] and similar to the 92% reported by
Hashim et al. [22], both lower than the 100% survival
rate reported here and by Borgonovo et al. [23].
The main purpose of this study was to measure mar-
ginal bone level changes after 1 year of follow-up. The
results of our study should be interpreted with caution
since the bone loss observed between surgery and T0
should be considered rather than MBL, bone remodel-
ing, because areas of the polished neck were subcrestal
at the time of implant placement. Twelve months after
surgery, MBL was 0.73 mm at the mesial aspect of the
implant and 0.83 mm at the distal aspect. These results
are comparable to those of. Grassi et al. [24], who ob-
served an average MBL of 0.83 mm after 12 months. A
recent systematic review comparing this kind of implants
versus titanium implants (Ti implants) reported an MBL
of 0.89 ± 0.18 mm favoring zirconia implants (Zi im-
plants) after 12–24 months [25]. The difference (0.14
mm) with the Ti implants was statistically significant
(p=0.053). Another study published by Kohal et al. [26]
Fig. 2 Changes in probing depth
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showed a higher MBL (1.31 ± 1.49 mm) between the
time of implant placement and 1 year of follow-up. Con-
versely, there are other studies reporting higher MBL,
such as that of Gahlert et al. [27], who observed an MBL
of 1.02 mm after 1 year in use.
Our study did not exclude cases that required minor
bone augmentation procedures during implant surgery,
and the prosthesis procedure began at 6–8 weeks post-
surgery, independently of requiring GBR or not because
it was considered that the minor GBR needed for treat
small dehiscences would not interfere with osteointegra-
tion [28]. Like other studies, we used bovine bone graft
covered with a resorbable collagen membrane [29–31].
A review that unified the data of these articles did not
find statistically significant differences in MBL between
applying guided bone regeneration (0.79 mm) and not
applying it (0.97 mm) [22]. In the present investigation,
we corroborate this statement since the MBL after 1 year
of loading was 0.61 mm in the cases where GBR was not
carried out compared to 0.94 mm in the cases where re-
generative procedures were applied (p=0.342). Although
one-piece implants do not allow primary closure of the
wound, procedures of minor bone augmentation did not
appear to have any significant effect on MBL [22, 28].
One of the advantages of one-piece implants is that they
might minimize bone loss by avoiding micromovements
and implant-abutment microgaps [32]. A systematic re-
view comparing one-piece implants versus two-piece im-
plants observed a statistically significant difference in
terms of MBL (0.93 ± 0.19 mm vs 1.46 ± 0.57 mm) [25].
Fig. 3 Changes in plaque index
Fig. 4 Changes in bleeding on probing index
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Conversely, the difficulty posed by these one-piece im-
plants is that they limit the prosthetic options for carrying
out the rehabilitation. Even preparing the implant head is
discouraged since, as observed by Silva et al. [14], it has a
negative influence on implant fracture. Furthermore, the
aging of this material in the presence of humidity at room
temperature is widely known. However, in vitro studies
[33, 34] evaluating the impact of low temperature degrad-
ation of Zr02 observe that the effect of aging was minimal
for these ceramic implants, suggesting a reliable clinical
application of this material. For this reason, it is an area
inconstant research and development to achieve implants
with greater resistance to fatigue and degradation.
The evaluation of clinical soft tissue parameters indi-
cated an absence of peri-implant biological complica-
tions, showing an average PD of 3.59 mm and BOP of
26.3% after 12 months. These data are comparable to
those obtained in a recent study published by Balmer
et al. [35] where they recorded an average PD of 3.47 ±
0.67 mm, which was slightly lower than what we ob-
served, and BOP of 57.5 ± 32.9%, which, conversely, was
higher than what we obtained. In some cases, BOP could
be identified as a clinical sign of mucositis due to incor-
rect plaque control or microgaps between the crown and
the implant [36]. Our probing depth was slightly higher
than that observed by Cionca et al. [37] in a systematic
review, where it ranged from 1.8 to 3.2 mm.
Conclusions
The results obtained with the Straumann® PURE Cer-
amic implants show them to exhibit very good clinical
behavior in terms of hard and soft tissue stability. The
survival rate of the implants of our pilot study was 9.9%.
For these reasons, we can conclude that implants could
be an alternative to titanium implants in the esthetic
zone. However, more long-term clinical studies are
necessary to confirm the clinical efficacy and the mech-
anical resistance of Zr02 as a material for the manufac-
ture of dental implants.
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